A new study found waste accounts for roughly one-quarter of
all U.S. healthcare spending, an estimate that's in the same ballpark as
its predecessors.
The cost of waste in the U.S.
healthcare system ranges from $760 billion to $935 billion annually,
according to a JAMA review of 54 peer-reviewed studies, government
reports and other information, released Monday. The study found
one-quarter of that could be cut using interventions found to reduce
waste.
Two previous studies on the subject from 2012 estimated waste at roughly 30% and 34% of total healthcare spending.
Shrank
undertook the research with a Humana colleague and a third researcher
from the University of Pittsburgh School of Medicine.
One
reason the new study's estimate is lower than previous ones is because
it took the conservative approach of not extrapolating Medicare-only
data to the broader population, whereas previous studies did. Shrank
said Medicare-only research represented the minority of contributing
studies.
The current study divided waste into six
previously identified categories. Administrative complexity accounted
for the most waste, at $265.6 billion annually. Below that was waste due
to pricing failure, which costs $230.7 billion to $240.5 billion
annually. Failure of care delivery accounts for $102.4 billion to $165.7
billion annually. Overtreatment or low-value care results in $75.7
billion to $101.2 billion in waste annually. Waste related to fraud and
abuse costs between $58.5 billion and $83.9 billion annually. Finally,
failure of care coordination generates $27.2 billion to $78.2 billion in
waste annually.
The study also estimated potential
annual savings from measures shown to cut waste. In aggregate, those
interventions could save $191 billion to $282 billion annually, or about
25% of the total cost of waste.
"There's always going to be some waste," Shrank said. "I don't think we'd ever expect to see zero waste."
But
there were no interventions in the scientific literature to chip away
at the biggest culprit: administrative waste. Shrank said that's because
those efforts tend to happen within businesses and aren't widely
disseminated. He hopes this study encourages more shared learning across
the healthcare industry.
The key takeaway theme of the
study, in Shrank's mind, is that aligning payers and providers through
value-based care initiatives can go a long way toward cutting waste. He
said sources of administrative complexity like prior authorization,
utilization management or other billing issues are simply methods payers
use to reduce waste.
"In an environment where payers
are pre-paying physicians or sharing risk with physicians for the
management of populations, much of these sources of administrative
complexity can be reduced or eliminated or streamlined," he said.
Other experts drew far different conclusions.
Former CMS Administrator Dr. Don Berwick, the Institute for Healthcare Improvement senior fellow who wrote a 2012 JAMA study on healthcare waste,
said value-based payment arrangements like bundled payments and
accountable care organizations have been shown to generate 1% to 3% in
cost savings—a "big gap" from the waste estimates researchers have
published.
"I tend to be an optimist and I'm grateful
for the progress, but I suspect we're going to need bolder approaches to
changing the financing of healthcare than we have accepted so far," he
said.
Similarly, Dr. Ashish Jha, professor of health
policy in the Harvard T.H. Chan School of Public Health, said research
has shown almost no value-based care programs have yielded improvement.
Even the most effective form of value-based care, physician-led ACOs,
have produced savings up to roughly 3%.
"I've got
literally dozens of studies I can point to that show it's having little
to no impact," he said. "This is not one where people just get to have
differing opinions. You've got to bring some evidence to bear for why
it's going to be useful, because all the data so far show things heading
in one direction."
Berwick said he thinks the solution
to healthcare waste will need to be a political one. People must
mobilize to say, " 'It's enough. We're not going to put up with this
kind of administrative waste,' " he said. " 'We're not going to put up
with this obscene pricing. It's time to stop.' I don't know without that
kind of political force, how these circumstances can be changed."
Jha
thinks part of the solution will be to address healthcare's irrational
pricing. One potential tool is price transparency improvement that will
help people shop around for the lowest-cost care, although there's not
much evidence that such efforts are helpful in lowering prices.
Enhanced
regulation of healthcare monopolies could also help, Jha said. In
recent years, he said federal agencies haven't adequately pushed back
against mergers and acquisitions, but that's partly because they're
underfunded. Another difficult but potentially helpful task would be to
either break up large health systems or enable new providers to enter
markets, he said. Jha said the federal government could lower drug
prices by importing generic drugs from other countries and potentially
negotiating drug prices directly.
Shrank believes
stronger payer and provider relationships will help chip away at waste
by allowing for more value-based partnerships. Those bonds must be built
on trust and transparency, he said.
"In the absence of
trust, that relationship is much more limited and our ability to take
better care of people and reduce waste similarly will be far more
limited," Shrank said.
No comments:
Post a Comment